Cargando…

Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides

Coronavirus disease-19, caused by the novel β-coronavirus SARS-CoV-2, has created a global pandemic unseen in a century. Rapid worldwide efforts have enabled the characterization of the virus and its pathogenic mechanism. An early key finding is that SARS-CoV-2 uses spike proteins, the virus' m...

Descripción completa

Detalles Bibliográficos
Autor principal:	Pomplun, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	RSC 2020
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128053/ https://www.ncbi.nlm.nih.gov/pubmed/34041482 http://dx.doi.org/10.1039/d0md00385a

Ejemplares similares

Computational Design of Miniproteins as SARS-CoV-2 Therapeutic Inhibitors
por: Jawad, Bahaa, et al.
Publicado: (2022)

Study of fusion peptide release for the spike protein of SARS-CoV-2
por: Yu, Jie, et al.
Publicado: (2023)

Smaller, Stronger, More Stable: Peptide Variants of a SARS-CoV-2 Neutralizing Miniprotein
por: Weißenborn, Lucas, et al.
Publicado: (2022)

De Novo Discovery of High-Affinity Peptide Binders for the SARS-CoV-2 Spike Protein
por: Pomplun, Sebastian, et al.
Publicado: (2020)

De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
por: Cao, Longxing, et al.
Publicado: (2020)

Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease
por: Case, James Brett, et al.
Publicado: (2021)

De novo design of a stapled peptide targeting SARS-CoV-2 spike protein receptor-binding domain
por: Thakkar, Ravindra, et al.
Publicado: (2023)

O-Glycosylation Landscapes of SARS-CoV-2 Spike Proteins
por: Zhang, Yong, et al.
Publicado: (2021)

Neutralizing antibodies targeting SARS-CoV-2 spike protein
por: Xiaojie, Shi, et al.
Publicado: (2021)

Ultrapotent miniproteins targeting the receptor-binding domain protect against SARS-CoV-2 infection and disease in mice
por: Case, James Brett, et al.
Publicado: (2021)

Potential antiviral peptides targeting the SARS-CoV-2 spike protein
por: Khater, Ibrahim, et al.
Publicado: (2022)

In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2
por: Ling, Rongsong, et al.
Publicado: (2020)

Spike protein multiorgan tropism suppressed by antibodies targeting SARS-CoV-2
por: Brady, Molly, et al.
Publicado: (2021)

An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
por: Liu, Yafei, et al.
Publicado: (2021)

Directed Self-Assembly of Trimeric DNA-Bindingchiral Miniprotein Helicates
por: Gómez-González, Jacobo, et al.
Publicado: (2018)

Antiviral cyclic peptides targeting the main protease of SARS-CoV-2
por: Johansen-Leete, Jason, et al.
Publicado: (2022)

Antibody detection of SARS-CoV spike and nucleocapsid protein
por: Chang, Mau-Sun, et al.
Publicado: (2004)

Interaction analyses of SARS-CoV-2 spike protein based on fragment molecular orbital calculations
por: Akisawa, Kazuki, et al.
Publicado: (2021)

Amino acid interacting network in the receptor-binding domain of SARS-CoV-2 spike protein
por: Adhikari, Puja, et al.
Publicado: (2020)

Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies
por: Hussain, Arif, et al.
Publicado: (2020)

Identification of Potential Binding Sites of Sialic Acids on the RBD Domain of SARS-CoV-2 Spike Protein
por: Li, Bingqian, et al.
Publicado: (2021)

Understanding the role of galectin inhibitors as potential candidates for SARS-CoV-2 spike protein: in silico studies
por: Sethi, Aaftaab, et al.
Publicado: (2020)

Development of high affinity broadly reactive aptamers for spike protein of multiple SARS-CoV-2 variants
por: Le, Thao T., et al.
Publicado: (2023)

Design and Engineering of Miniproteins
por: Ożga, Katarzyna, et al.
Publicado: (2022)

An In Silico Design of Peptides Targeting the S1/S2 Cleavage Site of the SARS-CoV-2 Spike Protein
por: Ho, Chian, et al.
Publicado: (2023)

DNA-binding miniproteins based on zinc fingers. Assessment of the interaction using nanopores
por: Rodríguez, Jéssica, et al.
Publicado: (2018)

Molecular dynamics modelling of the interaction of a synthetic zinc-finger miniprotein with DNA
por: Rodriguez, Jessica, et al.
Publicado: (2023)

SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies
por: Yang, Yang, et al.
Publicado: (2021)

Antibody-mediated immunity to SARS-CoV-2 spike
por: Errico, John M., et al.
Publicado: (2022)

Cold atmospheric pressure plasma for attenuation of SARS-CoV-2 spike protein binding to ACE2 protein and the RNA deactivation
por: Khanikar, Rakesh Ruchel, et al.
Publicado: (2022)

Performance of Elecsys Anti-SARS CoV-2 (Roche) and VIDAS Anti-SARS CoV-2 (Biomérieux) for SARS-CoV-2 Nucleocapsid and Spike Protein Antibody Detection
por: Inés, Riberi María, et al.
Publicado: (2022)

A urine-based ELISA with recombinant non-glycosylated SARS-CoV-2 spike protein for detecting anti-SARS-CoV-2 spike antibodies
por: Ramos, Fernanda F., et al.
Publicado: (2023)

SARS-CoV-2 virus-like-particles via liposomal reconstitution of spike glycoproteins
por: McColman, Sarah, et al.
Publicado: (2023)

Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike Protein
por: Hu, Xin, et al.
Publicado: (2021)

Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein
por: Yang, Kailu, et al.
Publicado: (2022)

SARS-CoV-2 spike S2-specific neutralizing antibodies
por: Li, Chia-Jung, et al.
Publicado: (2023)

Hydrazones and Thiosemicarbazones Targeting Protein-Protein-Interactions of SARS-CoV-2 Papain-like Protease
por: Ewert, Wiebke, et al.
Publicado: (2022)

Structure of SARS-CoV-2 spike protein
por: Zhang, Jun, et al.
Publicado: (2021)

Amyloidogenesis of SARS-CoV-2 Spike Protein
por: Nyström, Sofie, et al.
Publicado: (2022)

SARS-CoV-2 and the spike protein in endotheliopathy
por: Perico, Luca, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_suhhmubbk071os9d4omsib3d4k